OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors
Zheng Zhao, Philip E. Bourne
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1182-1191
Open Access | Times Cited: 8
Zheng Zhao, Philip E. Bourne
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1182-1191
Open Access | Times Cited: 8
Showing 8 citing articles:
Structure–Activity Relationship Study and Design Strategies of Hydantoin, Thiazolidinedione, and Rhodanine-Based Kinase Inhibitors: A Two-Decade Review
Muhammad Naufal, Elvira Hermawati, Yana Maolana Syah, et al.
ACS Omega (2024) Vol. 9, Iss. 4, pp. 4186-4209
Open Access | Times Cited: 8
Muhammad Naufal, Elvira Hermawati, Yana Maolana Syah, et al.
ACS Omega (2024) Vol. 9, Iss. 4, pp. 4186-4209
Open Access | Times Cited: 8
Exploring SureChEMBL from a drug discovery perspective
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Application of a macrocyclization strategy in kinase inhibitor development
Kun Xing, Shujun Li, Jing Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Kun Xing, Shujun Li, Jing Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations
Xuan Zheng, Zhiwen Chen, Ming Guo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1485-1506
Closed Access | Times Cited: 2
Xuan Zheng, Zhiwen Chen, Ming Guo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1485-1506
Closed Access | Times Cited: 2
Exploring Extended Warheads of Reversible and Irreversible Cysteine-Targeted Covalent Kinase Inhibitors
Zheng Zhao, Philip E. Bourne
(2024)
Open Access | Times Cited: 2
Zheng Zhao, Philip E. Bourne
(2024)
Open Access | Times Cited: 2
Exploring Extended Warheads toward Developing Cysteine-Targeted Covalent Kinase Inhibitors
Zheng Zhao, Philip E. Bourne
Journal of Chemical Information and Modeling (2024)
Open Access
Zheng Zhao, Philip E. Bourne
Journal of Chemical Information and Modeling (2024)
Open Access
Medicinal chemistry lens on patent data in SureChEMBL
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Medicinal chemistry lens on patent data in SureChEMBL
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
Research Square (Research Square) (2023)
Open Access
Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius, et al.
Research Square (Research Square) (2023)
Open Access
